Advertisement Lilly launches KwikPen insulin device - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lilly launches KwikPen insulin device

Eli Lilly and Company has launched KwikPen, a new insulin pen prefilled with the Humalog brand of insulins.

KwikPen is now available by prescription in pharmacies prefilled with the Humalog brand of insulins, including Humalog, Humalog Mix75/25 (75% insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin]) and Humalog Mix50/50 (50% insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin]).

The Humalog brand of insulins are indicated for use in patients with diabetes to control high blood sugar.